Posts With Tag therapeutic development

Showing 1 - 2 of 2 Posts

VistaGen Therapeutics Q4 2024 Financial Analysis: Hold Recommendation Amid Challenges

$VTGN

•

Form 10-Q

•

2025-02-13

Last updated: 3 months ago

VistaGen Therapeutics Q4 2024 Financial Analysis: Hold Recommendation Amid Challenges

Explore VistaGen Therapeutics, Inc.'s Q4 2024 report, highlighting cash position, accumulated deficit, and strategic recommendations for investors amid ongoing operating losses.

VistaGen Therapeutics biopharmaceutical neurology clinical trials therapeutic development

Radiopharm Theranostics Limited: December 2024 Form 6-K Report on RAD 202 Trial Approval

$RADX

•

Form 6-K

•

2024-12-20

Last updated: 5 months ago

Radiopharm Theranostics Limited: December 2024 Form 6-K Report on RAD 202 Trial Approval

Explore Radiopharm Theranostics Limited's December 2024 report detailing RAD 202's Phase 1 trial approval, reflecting key developments in their therapeutic pipeline and compliance status.

Radiopharm Theranostics Phase 1 clinical trial therapeutic development medical technology ASX announcement